Ho et al. previously demonstrated a significant correlation between CFU scores with the FACS quantification of EPCs via labelling of early stage (CD133+ VEGFR2+) and mature (CD34+ VEGFR2+) EPC populations from the peripheral blood in hepatocellular carcinoma patients14. This evidence concerns the gene PROM1 and hepatocellular carcinoma.